Piramal Pharma Limited (NSE: PPLPHARMA)

India flag India · Delayed Price · Currency is INR
252.20
-9.40 (-3.59%)
Dec 20, 2024, 3:30 PM IST
95.05%
Market Cap 334.35B
Revenue (ttm) 87.04B
Net Income (ttm) 453.30M
Shares Out 1.33B
EPS (ttm) 0.34
PE Ratio 737.60
Forward PE 77.31
Dividend 0.11 (0.04%)
Ex-Dividend Date Jul 12, 2024
Volume 5,270,879
Open 264.40
Previous Close 261.60
Day's Range 249.70 - 268.80
52-Week Range 114.35 - 307.90
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 22, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off... [Read more]

Sector Healthcare
Founded 2020
Employees 6,719
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.